{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:28:17Z","timestamp":1759940897676,"version":"3.40.5"},"publisher-location":"New York, NY","reference-count":28,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071629772"},{"type":"electronic","value":"9781071629789"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2978-9_4","type":"book-chapter","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:15:54Z","timestamp":1676330154000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Research Analysis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-2983","authenticated-orcid":false,"given":"Rosemary L.","family":"Sparrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Greening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,12]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/203312a0","volume":"203","author":"JG Pool","year":"1964","unstructured":"Pool JG, Gershgold EJ, Pappenhagen AR (1964) High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 203:312","journal-title":"Nature"},{"key":"4_CR2","first-page":"70","volume":"17(Suppl 84)","author":"JG Pool","year":"1965","unstructured":"Pool JG (1965) Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks. Scand J Clin Lab Invest 17(Suppl 84):70\u201387","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"4_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tmrv.2009.03.001","volume":"23","author":"JL Callum","year":"2009","unstructured":"Callum JL, Karkouti K, Lin Y (2009) Cryoprecipitate: the current state of knowledge. Transfus Med Rev 23(3):177\u2013188","journal-title":"Transfus Med Rev"},{"issue":"2","key":"4_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/j.seminhematol.2020.07.006","volume":"57","author":"PM Nair","year":"2020","unstructured":"Nair PM, Rendo MJ, Reddoch-Cardenas KM, Burris JK, Meledeo MA, Cap AP (2020) Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease. Semin Hematol 57(2):73\u201382. https:\/\/doi.org\/10.1053\/j.seminhematol.2020.07.006","journal-title":"Semin Hematol"},{"issue":"8079","key":"4_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(78)91324-7","volume":"2","author":"EC Mason","year":"1978","unstructured":"Mason EC (1978) Thaw-siphon technique for production of cryoprecipitate concentrate of factor VIII. Lancet 2(8079):15\u201317","journal-title":"Lancet"},{"issue":"1","key":"4_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1537-2995.1979.19179160274.x","volume":"19","author":"GA Rock","year":"1979","unstructured":"Rock GA, Tittley P (1979) The effects of temperature variations on cryoprecipitate. Transfusion 19(1):86\u201389","journal-title":"Transfusion"},{"issue":"5","key":"4_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1423-0410.1979.tb04437.x","volume":"36","author":"GA Rock","year":"1979","unstructured":"Rock GA, Cruickshank WH, Tackaberry ES, Palmer DS (1979) Improved yields of factor VIII from heparinized plasma. Vox Sang 36(5):294\u2013300","journal-title":"Vox Sang"},{"key":"4_CR8","first-page":"60a","volume":"98","author":"E Shanbrom","year":"2001","unstructured":"Shanbrom E, Owens WJ (2001) A novel method to enhance the formation of cryoprecipitate from fresh plasma. Blood 98:60a","journal-title":"Blood"},{"issue":"4","key":"4_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-2257.2006.00785.x","volume":"28","author":"H Yousef","year":"2006","unstructured":"Yousef H, Neurath D, Freedman M, Rock G (2006) Cryoprecipitate production: the use of additives to enhance the yield. Clin Lab Haematol 28(4):237\u2013240","journal-title":"Clin Lab Haematol"},{"key":"4_CR10","volume-title":"AABB Technical Manual","author":"CS Cohn","year":"2020","unstructured":"Cohn CS, Delaney M, Johnson ST, LM K (2020) AABB Technical Manual, vol 20"},{"key":"4_CR11","first-page":"222\u2013228","volume":"38(4)","author":"RT Wensley","year":"1980","unstructured":"Wensley RT, Snape TJ (1980) Preparation of improved cryoprecipitated factor VIII concentrate. A controlled study of three variables affecting the yield. Vox Sang 38(4):222\u2013228","journal-title":"Vox Sang"},{"issue":"3","key":"4_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000119543","volume":"26","author":"E Meilin","year":"2008","unstructured":"Meilin E, Sela S, Kristal B (2008) Heparin cryoprecipitation reduces plasma levels of non-traditional risk factors for atherosclerosis in vitro. Blood Purif 26(3):238\u2013248","journal-title":"Blood Purif"},{"issue":"4","key":"4_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/ALN.0b013e3181672668","volume":"108","author":"NM Elkassabany","year":"2008","unstructured":"Elkassabany NM, Meny GM, Doria RR, Marcucci C (2008) Green plasma-revisited. Anesthesiology 108(4):764\u2013765. https:\/\/doi.org\/10.1097\/ALN.0b013e3181672668","journal-title":"Anesthesiology"},{"issue":"Pt 5","key":"4_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1258\/acb.2012.012032","volume":"49","author":"V Brunel","year":"2012","unstructured":"Brunel V, Larson T, Peschanski N, Cauliez B (2012) Evaluation of haemolysis in emergency department samples requesting high sensitivity troponin T measurement. Ann Clin Biochem 49(Pt 5):509\u2013510. https:\/\/doi.org\/10.1258\/acb.2012.012032","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"4_CR15","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1537-2995.2011.03079.x","volume":"51","author":"K Peffer","year":"2011","unstructured":"Peffer K, de Kort WL, Slot E, Doggen CJ (2011) Turbid plasma donations in whole blood donors: fat chance? Transfusion 51(6):1179\u20131187. https:\/\/doi.org\/10.1111\/j.1537-2995.2011.03079.x","journal-title":"Transfusion"},{"issue":"6","key":"4_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/trf.13571","volume":"56","author":"L Green","year":"2016","unstructured":"Green L, Backholer L, Wiltshire M, Platton S, Stanworth SJ, Cardigan R (2016) The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours. Transfusion 56(6):1356\u20131361. https:\/\/doi.org\/10.1111\/trf.13571","journal-title":"Transfusion"},{"issue":"2","key":"4_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/trf.12254","volume":"54","author":"V Bhakta","year":"2014","unstructured":"Bhakta V, Jenkins C, Ramirez-Arcos S, Sheffield WP (2014) Stability of relevant plasma protein activities in cryosupernatant plasma units during refrigerated storage for up to 5 days postthaw. Transfusion 54(2):418\u2013425. https:\/\/doi.org\/10.1111\/trf.12254","journal-title":"Transfusion"},{"key":"4_CR18","volume-title":"Standards for blood banks and transfusion services","author":"RR Gammon","year":"2022","unstructured":"Gammon RR (2022) Standards for blood banks and transfusion services, vol 33. AABB"},{"issue":"5","key":"4_CR19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/00000539-200011000-00042","volume":"91","author":"HJ Gorton","year":"2000","unstructured":"Gorton HJ, Warren ER, Simpson NA, Lyons GR, Columb MO (2000) Thromboelastography identifies sex-related differences in coagulation. Anesth Analg 91(5):1279\u20131281. https:\/\/doi.org\/10.1097\/00000539-200011000-00042","journal-title":"Anesth Analg"},{"issue":"2","key":"4_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1055\/s-0035-1564845","volume":"42","author":"G Ramsey","year":"2016","unstructured":"Ramsey G (2016) Hemostatic efficacy of pathogen-inactivated blood components. Semin Thromb Hemost 42(2):172\u2013182. https:\/\/doi.org\/10.1055\/s-0035-1564845","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"4_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2450\/2020.0077-20","volume":"18","author":"RW Kamyszek","year":"2020","unstructured":"Kamyszek RW, Foster MW, Evans BA, Stoner K, Poisson J, Srinivasan AJ, Thompson JW, Moseley MA, Mooberry MJ, Welsby IJ (2020) The effect of pathogen inactivation on cryoprecipitate: a functional and quantitative evaluation. Blood Transfus 18(6):454\u2013464. https:\/\/doi.org\/10.2450\/2020.0077-20","journal-title":"Blood Transfus"},{"issue":"8","key":"4_CR22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/trf.12602","volume":"54","author":"KS Chan","year":"2014","unstructured":"Chan KS, Sparrow RL (2014) Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold. Transfusion 54(8):1935\u20131944. https:\/\/doi.org\/10.1111\/trf.12602","journal-title":"Transfusion"},{"issue":"1","key":"4_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1182\/blood.V68.1.307.307","volume":"68","author":"JN George","year":"1986","unstructured":"George JN, Pickett EB, Heinz R (1986) Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 68(1):307\u2013309","journal-title":"Blood"},{"key":"4_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.734720","volume":"9","author":"B Claridge","year":"2021","unstructured":"Claridge B, Lozano J, Poh QH, Greening DW (2021) Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities. Front Cell Dev Biol 9:734720. https:\/\/doi.org\/10.3389\/fcell.2021.734720","journal-title":"Front Cell Dev Biol"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2015.02.009","volume":"40","author":"DW Greening","year":"2015","unstructured":"Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W (2015) Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol 40:72\u201381. https:\/\/doi.org\/10.1016\/j.semcdb.2015.02.009","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"4_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","volume":"15","author":"R Xu","year":"2018","unstructured":"Xu R, Rai A, Chen M, Suwakulsiri W, Greening DW, Simpson RJ (2018) Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol 15(10):617\u2013638. https:\/\/doi.org\/10.1038\/s41571-018-0036-9","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"4_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","volume":"23","author":"G van Niel","year":"2022","unstructured":"van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P (2022) Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol 23(5):369\u2013382. https:\/\/doi.org\/10.1038\/s41580-022-00460-3","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4_CR28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1080\/14789450.2018.1537788","volume":"15","author":"DW Greening","year":"2018","unstructured":"Greening DW, Simpson RJ (2018) Understanding extracellular vesicle diversity - current status. Expert Rev Proteomics 15(11):887\u2013910. https:\/\/doi.org\/10.1080\/14789450.2018.1537788","journal-title":"Expert Rev Proteomics"}],"container-title":["Methods in Molecular Biology","Serum\/Plasma Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2978-9_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:34:22Z","timestamp":1676331262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2978-9_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071629772","9781071629789"],"references-count":28,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2978-9_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"12 February 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}